| Literature DB >> 15221118 |
Abstract
Levobupivacaine, the S-enantiomer of racemic bupivacaine, will be available in Germany in mid-2004. Pharmacological studies demonstrated that, compared to bupivacaine, levobupivacaine has equal local anaesthetic potency with reduced potential for cardiac and CNS toxicity. This review introduces the new long-acting amide local anaesthetic levobupivacaine to the reader and evaluates its place in obstetric analgesia and anaesthesia compared to bupivacaine and ropivacaine.Entities:
Mesh:
Substances:
Year: 2004 PMID: 15221118 DOI: 10.1007/s00101-004-0706-0
Source DB: PubMed Journal: Anaesthesist ISSN: 0003-2417 Impact factor: 1.041